Showing results (1151-1160 of 3,790) with videos related to
Sort By:
Pageof 379
Oncoimmunology|June 28, 2012
Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosisSana Intidhar Labidi-Galy, Isabelle Treilleux, Sophie Goddard-Leon, et al.Oncoimmunology|June 28, 2012
Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cellsJayakumar R Nair, Cheryl H Rozanski, Kelvin P LeeOncoimmunology|June 28, 2012
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39Mickaël Michaud, Abdul Qader Sukkurwala, Isabelle Martins, et al.Oncoimmunology|June 28, 2012
Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapyTakemasa Tsuji, Sacha GnjaticOncoimmunology|July 4, 2012
Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapyGuido Kroemer, Laurence ZitvogelOncoimmunology|July 4, 2012
TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patientsPia Kvistborg, Chengyi Jenny Shu, Bianca Heemskerk, et al.Oncoimmunology|July 4, 2012
Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patientsA J Robert McGray, Dannie Bernard, Robin Hallett, et al.Oncoimmunology|July 4, 2012
Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10Lazar Vujanovic, Wenners Ballard, Stephen H Thorne, et al.Oncoimmunology|July 4, 2012
Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivoNai-Kong V Cheung, Hongfen Guo, Jian Hu, et al.Oncoimmunology|July 4, 2012
Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of gliomaGary Kohanbash, Eiichi Ishikawa, Mitsugu Fujita, et al.Pageof 379